Bailard, Inc. Abbott Laboratories Transaction History

Bailard, Inc.

$3.6 Billion
Q2 2024

A detailed history of Bailard, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Bailard, Inc. holds 76,792 shares of ABT stock, worth $8.62 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

76,792

Previous 77,219 0.55%

Holding current value

$8.62 Million

Previous $8.78 Million 9.08%

% of portfolio

0.22%

Previous 0.25%

38 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$100.73 - $112.44 $43,011 - $48,011	-427 Reduced 0.55%	76,792 $7.98 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $3,504 - $3,870	-32 Reduced 0.04%	77,219 $8.78 Million
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $30,123 - $36,873	-334 Reduced 0.43%	77,251 $8.5 Million
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $696,986 - $836,267	7,296 Added 10.38%	77,585 $7.51 Million
Q2 2023 Jul 20, 2023	SELL	$100.78 - $112.29 $704,552 - $785,019	-6,991 Reduced 9.05%	70,289 $7.66 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $44,943 - $52,900	-464 Reduced 0.6%	77,280 $7.83 Million
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $104,756 - $122,895	-1,102 Reduced 1.4%	77,744 $8.54 Million
Q3 2022 Oct 18, 2022	BUY	$96.76 - $112.03 $33,285 - $38,538	344 Added 0.44%	78,846 $7.63 Million
Q2 2022 Jul 27, 2022	SELL	$102.07 - $123.37 $140,550 - $169,880	-1,377 Reduced 1.72%	78,502 $8.53 Million
Q1 2022 Apr 25, 2022	SELL	$114.02 - $139.04 $51,194 - $62,428	-449 Reduced 0.56%	79,879 $9.46 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $24,607 - $30,130	213 Added 0.27%	80,328 $11.3 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $17,499 - $19,359	150 Added 0.19%	80,115 $9.46 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $378,305 - $445,319	-3,576 Reduced 4.28%	79,965 $9.27 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $7.01 Million - $8.26 Million	64,386 Added 336.13%	83,541 $10 Million
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $235,305 - $256,415	2,241 Added 13.25%	19,155 $2.1 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $88,615 - $107,617	967 Added 6.06%	16,914 $1.84 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $50,229 - $64,288	656 Added 4.29%	15,947 $1.46 Million
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $22,363 - $32,702	-356 Reduced 2.28%	15,291 $1.21 Million
Q4 2019 Jan 31, 2020	BUY	$78.51 - $87.4 $2,512 - $2,796	32 Added 0.2%	15,647 $1.36 Million
Q3 2019 Oct 18, 2019	SELL	$81.84 - $88.74 $3,273 - $3,549	-40 Reduced 0.26%	15,615 $1.31 Million
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $5,830 - $6,800	-80 Reduced 0.51%	15,655 $1.32 Million
Q1 2019 Apr 24, 2019	BUY	$66.22 - $80.06 $95,290 - $115,206	1,439 Added 10.07%	15,735 $1.26 Million
Q4 2018 Feb 05, 2019	BUY	$65.56 - $74.27 $54,283 - $61,495	828 Added 6.15%	14,296 $1.03 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $86,775 - $104,684	1,427 Added 11.85%	13,468 $988,000
Q2 2018 Aug 08, 2018	SELL	$57.57 - $63.54 $18,422 - $20,332	-320 Reduced 2.59%	12,041 $734,000
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $24,477 - $27,674	-435 Reduced 3.4%	12,361 $741,000
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $16,104 - $17,241	300 Added 2.4%	12,796 $0
Q3 2017 Oct 11, 2017	SELL	$48.06 - $53.64 $12,015 - $13,410	-250 Reduced 1.96%	12,496 $667,000
Q2 2017 Aug 11, 2017	SELL	N/A	-1,865 Reduced 12.76%	12,746 $0
Q1 2017 Jan 29, 2018	BUY	N/A	51 Added 0.35%	14,611 $649,000
Q4 2016 Jan 29, 2018	SELL	N/A	-2,024 Reduced 12.2%	14,560 $0
Q3 2016 Jan 29, 2018	BUY	N/A	6,248 Added 60.45%	16,584 $701,000
Q2 2016 Jan 29, 2018	BUY	N/A	3,687 Added 55.45%	10,336 $0
Q1 2016 Jan 29, 2018	SELL	N/A	-448 Reduced 6.31%	6,649 $278,000
Q3 2015 Jan 29, 2018	SELL	N/A	-803 Reduced 10.16%	7,097 $285,000
Q2 2015 Jan 29, 2018	SELL	N/A	-80 Reduced 1.0%	7,900 $0
Q1 2015 Jan 29, 2018	BUY	N/A	458 Added 6.09%	7,980 $370,000
Q4 2014 Jan 29, 2018	BUY	N/A	7,522	7,522 $0

Others Institutions Holding ABT

# of Institutions

3,138

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account